U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585396) titled 'Inositol in Letrozol Resistant PCOS Women' on May 07.
Brief Summary: Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.
Study Start Date: May 14
Study Type: INTERVENTIONAL
Condition:
Polycystic Ovary Syndrome
Letrozol Resistant
Intervention:
DRUG: Myoinositol
Combined myoinositol & Dchiroinositol twice daily plus letrozole for 3 months
DRUG: M...